BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun AND Diagnosis
14 results:

  • 1. Gene Differential Expression and Interaction Networks Illustrate the Biomarkers and Molecular Biological Mechanisms of Unsaponifiable Matter in Kanglaite Injection for pancreatic Ductal Adenocarcinoma.
    Xu B; Dan W; Zhang X; Wang H; Cao L; Li S; Li J
    Biomed Res Int; 2022; 2022():6229462. PubMed ID: 35707377
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Highly sensitive and portable mRNA detection platform for early cancer detection.
    Li H; Warden AR; Su W; He J; Zhi X; Wang K; Zhu L; Shen G; Ding X
    J Nanobiotechnology; 2021 Sep; 19(1):287. PubMed ID: 34565398
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effect of miR-184 on Proliferation and Apoptosis of pancreatic Ductal Adenocarcinoma and Its Mechanism.
    Li S; Li H; Ge W; Song K; Yuan C; Yin R
    Technol Cancer Res Treat; 2020; 19():1533033820943237. PubMed ID: 32914707
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Irreversible JNK1-jun inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy.
    Lipner MB; Peng XL; Jin C; Xu Y; Gao Y; East MP; Rashid NU; Moffitt RA; Herrera Loeza SG; Morrison AB; Golitz BT; Vaziri C; Graves LM; Johnson GL; Yeh JJ
    JCI Insight; 2020 Apr; 5(8):. PubMed ID: 32213714
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A FAM83A Positive Feed-back Loop Drives Survival and Tumorigenicity of pancreatic Ductal Adenocarcinomas.
    Parameswaran N; Bartel CA; Hernandez-Sanchez W; Miskimen KL; Smigiel JM; Khalil AM; Jackson MW
    Sci Rep; 2019 Sep; 9(1):13396. PubMed ID: 31527715
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A primary splenic angiosarcoma hepatic metastasis after splenectomy and its genomic alteration profile.
    Cao L; Hong J; Wang Y; Yu J; Ma R; Li J; Wu J; Zheng S
    Medicine (Baltimore); 2019 Jul; 98(28):e16245. PubMed ID: 31305404
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway.
    Wang X; Wu X; Zhang Z; Ma C; Wu T; Tang S; Zeng Z; Huang S; Gong C; Yuan C; Zhang L; Feng Y; Huang B; Liu W; Zhang B; Shen Y; Luo W; Wang X; Liu B; Lei Y; Ye Z; Zhao L; Cao D; Yang L; Chen X; Haydon RC; Luu HH; Peng B; Liu X; He TC
    Sci Rep; 2018 Dec; 8(1):17914. PubMed ID: 30559409
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Laparoscopic ultrasound: a surgical "must" for second line intra-operative evaluation of pancreatic cancer resectability.
    Piccolboni P; Settembre A; Angelini P; Esposito F; Palladino S; Corcione F
    G Chir; 2015; 36(1):5-8. PubMed ID: 25827662
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Calix[6]arene bypasses human pancreatic cancer aggressiveness: downregulation of receptor tyrosine kinases and induction of cell death by reticulum stress and autophagy.
    Pelizzaro-Rocha KJ; de Jesus MB; Ruela-de-Sousa RR; Nakamura CV; Reis FS; de Fátima A; Ferreira-Halder CV
    Biochim Biophys Acta; 2013 Dec; 1833(12):2856-2865. PubMed ID: 23872419
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of death receptor signaling on the malignancy of pancreatic ductal adenocarcinoma.
    Röder C; Trauzold A; Kalthoff H
    Eur J Cell Biol; 2011; 90(6-7):450-5. PubMed ID: 21129814
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Loss of tyrosine phosphatase-dependent inhibition promotes activation of tyrosine kinase c-Src in detached pancreatic cells.
    Connelly SF; Isley BA; Baker CH; Gallick GE; Summy JM
    Mol Carcinog; 2010 Dec; 49(12):1007-21. PubMed ID: 20945416
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Venous thromboembolism in patients with pancreatic adenocarcinoma: lower incidence in Asian ethnicity.
    Oh SY; Kim JH; Lee KW; Bang SM; Hwang JH; Oh D; Lee JS
    Thromb Res; 2008; 122(4):485-90. PubMed ID: 18234292
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.
    Sclabas GM; Fujioka S; Schmidt C; Li Z; Frederick WA; Yang W; Yokoi K; Evans DB; Abbruzzese JL; Hess KR; Zhang W; Fidler IJ; Chiao PJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):440-9. PubMed ID: 15701826
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The antagonistic regulation of human MUC4 and ErbB-2 genes by the Ets protein PEA3 in pancreatic cancer cells: implications for the proliferation/differentiation balance in the cells.
    Fauquette V; Perrais M; Cerulis S; Jonckheere N; Ducourouble MP; Aubert JP; Pigny P; Van Seuningen I
    Biochem J; 2005 Feb; 386(Pt 1):35-45. PubMed ID: 15461591
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.